Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies

With widespread global COVID-19 vaccine coverage, a scalable, cost-effective, and standardized tool to ascertain post-vaccine immunity is a dire need. Neither clinical evaluations of vaccine efficacy, nor live virus antibody neutralization assays fulfill these criteria. Commercially available anti-S...

Descripción completa

Detalles Bibliográficos
Autores principales: Aijaz, Javeria, Kanani, Fatima, Naseer, Fouzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832685/
https://www.ncbi.nlm.nih.gov/pubmed/36644775
http://dx.doi.org/10.1016/j.jcvp.2023.100137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832685/
https://www.ncbi.nlm.nih.gov/pubmed/36644775
http://dx.doi.org/10.1016/j.jcvp.2023.100137

Ejemplares similares